H O M E W A R E P RO D U C T S M A N U FAC T U R E R C L I P & L O C K C L O S U R E • Food contact compliance • Good compatibility • Excellent hinging properties • Reduce strain marks • Retain clarity • Provided extensive technical support throughout formulation development • Met exact mechanical properties, provided excellent hinging properties and reduced strain whitening marks • Increased flexibility & lowered temperature flexing properties • Enabled customer to differentiate products & add value for the end consumer Versaflex™ Thermoplastic Elastomer KEY REQUIREMENTS WHY AVIENT?

M E D I C A L E Q U I P M E N T M A N U FA C T U R E R C L O S E D S Y S T E M D R U G T R A N S F E R D E V I C E • A new material for a seal inside the next generation of closed system drug transfer device • Compliance with stringent regulatory standards: • Biocompatibility to ISO10993 • USP VI compliance • Provided regulatory support services and expertise throughout extensive medical approval process • Provided a custom formulation compliant with the highest healthcare regulatory standards • Enabled material to be manufactured and shipped globally Custom Versalloy™ HC 9220-90 Formulation KEY REQUIREMENTS WHY AVIENT?

E U R O P E A N M E D I C A L D E V I C E M A N U FA C T U R E R F A C E M A S K V E N T I L A T I O N V A L V E • ISO 9001 and USP VI compliant • Compatible with overmolding onto PP • Translucent and highly colorable • Soft touch • Provided valuable regulatory support and documentation, enabling faster internal trials and material qualification for this customer • Worked together with customer to select the best material from a broad portfolio of medical TPE grades • Trusted as a polymer supplier for multiple healthcare applications Dynaflex™ G2711 Thermoplastic Elastomer KEY REQUIREMENTS WHY AVIENT?

Home printer OEM HOME PRINTER OEM R E C Y C L E D H I P S I N J E C T I O N C O V E R O F P R I N T E R • Provide PCR-based colorants for a more sustainable solution • Meet both color and mechanical requirements in PCR materials • Offer user-friendly PCR + Colorants solution to address the batch variance problem of PCR in an economical way • Offered revolutionary supply model of PCR + Colorants, ensuring precise quality and color • Helped customers solve the batch variance problem of PCR in a digital way and shortened the color-matching time with PCR Color Prediction Service • Provided on-site technical support to customer Rejoin PCR Colorants KEY REQUIREMENTS WHY AVIENT?

I N J E C T IO N M O L D E R T O U C H S C R E E N S U R F A C E • Provide antimicrobial protection with strong log reduction (gram-negative / gram-positive efficacy) using globally available and cost-effective active ingredients • Incorporate a compatible recycled base resin • Utilize recyclate with no haze or discoloration (yellowing) of product, even with long-term heat aging • Maintain visual clarity while using antimicrobial raw materials with additional functional additives • Offered expertise in antimicrobial solutions, application development, and versatile product forms • Provided non-public health claims and reduced material use with recycled polycarbonate • Delivered strong efficacy >Log 2 against gram- negative and gram-positive bacteria • Supported a safe, hygienic environment while maintaining clarity and performance using a masterbatch with recycled content Cesa WithStand SX Low Haze Antimicrobial Additives KEY REQUIREMENTS WHY AVIENT?

W H AT W E D O : M AT E R I A L S C I E N C E 4 CUSTOM FORMULATION We sell solutions not commodities. D is t. ) K W R R P M P P G A V Y F U L G C P IF F H X L F M C F O E H U N E C L K R A E M N A S H C E S C L G R A A L B Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of 2021年4月27日 Avient reflects 2021 estimated revenue of $4,300M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 84% Median: 77% H I G H F R E E C A S H F L OW C O N V E R S I O N Avient reflects 2021 estimated EBITDA of $560M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of 2021年4月27日 87 89 87 86 82 81 76 88 87 84 82 81 78 77 77 77 76 73 70 69 50 19 A vi e n t K W R P P G R P M A V Y F U L G C P F M C IF F H X L U N V R E C L A S H C E B N R F O E E M N G R A H U N K R A S C L A L B Source: Peer data per Bloomberg market data as of 2021年4月27日 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the majority of our chemical peers.

AU TO M O T I V E M I R R O R & C A M E R A M A N U FA C T U R E R C A B L E G R O M M E T • Electrically conductive

G L O B A L E L E C T R I C A L E Q U I P M E N T P R OV I D E R S W I T C H G E A R P L U N G E R • Customer looking to replace metal. Material needs to: • Pass ampere test at 10A and 16A conditions • Pass glow wire test at 750°C at 1.5mm thickness • Have a lubrication effect and dimensional stability at an elevated temperature of 110°C • Meet test criteria of 250K cycles switch on/off without failure or dimensional changes • Reduced risk of shock by replacing brass with polymer formulation that met all key electrical and functional performance criteria • Eliminated the need for secondary lubricant due to self- lubricating properties of LubriOne materials • Enabled in-house molding which removed reliance on external part supplier and allowed direct management of global inventory levels LubriOne™ Internally Lubricated Formulations KEY REQUIREMENTS WHY AVIENT?

C O S M E T I C PA C K A G I N G M A N U FA C T U R E R P E R F U M E C A P • A weighted material with a metallic finish • A material that could be injection molded into a premium perfume cap • Formulated a weighted material with 2.0 specific gravity that is FDA approved • Enabled customer to enter the premium packaging market, typically reserved for metal working converters • Provided a material that could be injection molded • Provided metallic finish aesthetic with cool touch haptics Gravi-Tech™ Density Modified Formulation KEY REQUIREMENTS WEIGHT + PROCESSABILITY LEARN MORE Copyright © 2021, Avient Corporation.

GUIDANCE ( T O TA L C O M PA N Y ) 11 $845 $846 Guidance Actual $125 $134 Guidance Actual Sales Adjusted EBITDA (in millions) $0.55 $0.63 Guidance Actual Adjusted EPS (in millions) Q1 2023 PERFORMANCE VS. Avient Specialty Formulators Other Specialty / Chemical Companies 2023E(%) 37 79 89 83 81 76 73 90 82 77 76 74 70 58 22 A vi e n t K W R P P G F U L A V Y R P M F M C C E H X L A S H E C L H U N E M N S C L M U LT I P L E E X PA N S I O N Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of 2023年5月31日 Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $36.50. Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years. 38 EV / 2023E EBITDA Historic Multiple 6.5 8.3 9.6 13.2 13.0 12.8 11.3 8.6 17.9 16.8 10.7 8.8 8.8 8.7 7.5 6.9 A vi e n t (2 0 1 1 ) A vi e n t (2 0 1 8 ) A vi e n t (2 0 2 3 ) K W R P P G R P M A V Y F U L E C L H X L F M C S C L C E A S H E M N H U N Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.